Region-specific cortico-striatal transcriptomic remodeling following early postnatal dopaminergic disturbance

bioRxiv — Neuroscience preprints · 2026-05-20 · open original →

Dopamine signaling plays critical roles in postnatal brain development, yet the molecular consequences of early dopaminergic disturbance remain incompletely understood. Here, we investigated…

Connects: Dopamine metabolism & DOPAL ↔ Mitochondrial dysfunction · Dopamine metabolism & DOPAL ↔ Synaptic & vesicular dysfunction · Dopamine metabolism & DOPAL ↔ Oxidative stress

Reader summary

by xavier.grehant on 2026-05-25

Dopamine metabolism & DOPAL Mitochondrial dysfunction Synaptic & vesicular dysfunction Oxidative stress Neuroinflammation

Study type: animal model (mouse) — not a Parkinson's disease trial or human study. Researchers gave newborn mice a small dose of 6-hydroxydopamine (6-OHDA) — the same chemical used to model dopamine neuron loss in adult PD research — on the fifth day of life. Three weeks later they measured which genes were switched on or off in two key brain areas: the prefrontal cortex (PFC, the brain's executive-control hub) and the striatum (STR, the movement and habit hub that is devastated in PD). The mice showed hyperactivity and impulsive behaviour, resembling ADHD rather than parkinsonism — the paper is primarily framed as a neurodevelopment study. Even so, its molecular findings speak directly to mechanisms central to Parkinson's.

The team identified 369 gene-expression changes in the PFC and 493 in the striatum, with strikingly different patterns in each region. Striatal changes clustered around locomotor regulation, extracellular matrix remodelling (the protein scaffold surrounding neurons), and the response to dopamine-acting drugs. Prefrontal changes centred on cortical development and cell-surface signalling. A network analysis grouped co-active genes into 32 clusters. Two clusters tied to mitochondrial energy production and the citric-acid cycle were suppressed by dopamine loss; a third cluster enriched for reactive oxygen species and hydrogen peroxide responses was switched on — echoing the mitochondrial and oxidative stress signatures seen in the substantia nigra in Parkinson's. Striatum-specific clusters pointed to immune-related pathways, including macrophage signalling and nitric oxide responses.

For people living with Parkinson's, this is foundational science rather than an actionable finding — it will not change treatment in the near term. Its value is that it maps, gene by gene, how dopamine loss rewires the corticostriatal circuit. The mitochondrial, synaptic, and immune-related pathways disturbed in this developmental mouse model are the same ones implicated in adult PD neurodegeneration. Researchers can use this molecular atlas when searching for why particular neurons become vulnerable and what early molecular warning signs of dopaminergic circuit failure look like.

What this article adds

Dopamine metabolism & DOPAL: A mouse study using early postnatal 6-OHDA (the same dopamine-depleting neurotoxin used in adult PD models) found 369 gene-expression changes in the prefrontal cortex and 493 in the striatum, with region-specific patterns: cortical changes reflected developmental and signalling programs, while striatal changes reflected locomotor regulation, extracellular matrix organisation, and amphetamine response. The results provide a gene-level map of how dopamine loss reshapes corticostriatal molecular programs — relevant to understanding why circuits fail in PD.
Mitochondrial dysfunction: Gene co-expression network analysis identified two clusters negatively correlated with early dopaminergic disturbance: the "black" module (mitochondrial ATP synthesis, cellular respiration) and the "brown" module (tricarboxylic acid cycle, mitochondrial electron transport, ubiquitin-independent protein catabolism). A third cluster positively correlated with dopamine loss ("midnightblue") was linked to oxidative phosphorylation and reactive oxygen species responses, suggesting that dopamine loss triggers both a deficit and a compensatory stress response in mitochondrial gene programs within the corticostriatal circuit.
Synaptic & vesicular dysfunction: Prefrontal-cortex-specific co-expression modules following early dopamine loss were linked to trans-synaptic signalling and chemical synaptic transmission ("darkred" and "grey60" modules); in the striatum, gene changes were enriched in excitatory neuronal signatures and extracellular matrix organisation — a scaffold critical for synaptic stabilisation. This region-specific remodelling of synaptic gene networks by dopaminergic disturbance maps a circuit-level vulnerability relevant to PD.
Oxidative stress: A gene co-expression module positively correlated with early dopaminergic disturbance (the "midnightblue" module) was enriched for oxidative phosphorylation, response to reactive oxygen species, and response to hydrogen peroxide, indicating that dopamine loss — even at a developmental stage — triggers an oxidative stress transcriptional program in corticostriatal circuits consistent with the ROS signature described in nigral degeneration in Parkinson's.
Neuroinflammation: Striatum-specific co-expression modules following early dopaminergic disturbance included immune-related gene clusters: the "darkorange" module was linked to macrophage colony-stimulating factor response and nitric oxide signalling, while the "white" module was associated with leukocyte-mediated immunity. Cell-type enrichment analyses also identified signals in pericytes and vascular leptomeningeal cells, pointing to vascular-immune involvement in the dopamine-depleted striatum — a pattern consistent with neuroinflammatory changes reported in PD.

Contribute an improved analysis →